|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-13
|
|
pubmed:abstractText |
Alzheimer disease and cerebrovascular disease affect elderly persons through alterations in brain structure and metabolism that produce cognitive decline. Understanding how each disease contributes to dementia is essential from both a pathophysiologic and diagnostic perspective.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-10681076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-11406925,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-1202204,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-12058091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-12154149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-12205587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-12959504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-15277616,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-16513006,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-17112749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-2370355,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-6610841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-9052711,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18474742-9447441
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1538-3687
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
650-5
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:18474742-Aged,
pubmed-meshheading:18474742-Aged, 80 and over,
pubmed-meshheading:18474742-Alzheimer Disease,
pubmed-meshheading:18474742-Atrophy,
pubmed-meshheading:18474742-Brain,
pubmed-meshheading:18474742-Brain Diseases, Metabolic,
pubmed-meshheading:18474742-Brain Mapping,
pubmed-meshheading:18474742-Cognition Disorders,
pubmed-meshheading:18474742-Cross-Sectional Studies,
pubmed-meshheading:18474742-Dementia, Vascular,
pubmed-meshheading:18474742-Disease Progression,
pubmed-meshheading:18474742-Energy Metabolism,
pubmed-meshheading:18474742-Female,
pubmed-meshheading:18474742-Glucose,
pubmed-meshheading:18474742-Hippocampus,
pubmed-meshheading:18474742-Humans,
pubmed-meshheading:18474742-Male,
pubmed-meshheading:18474742-Memory Disorders,
pubmed-meshheading:18474742-Nerve Fibers, Myelinated,
pubmed-meshheading:18474742-Neuropsychological Tests,
pubmed-meshheading:18474742-Positron-Emission Tomography,
pubmed-meshheading:18474742-Predictive Value of Tests
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
|
|
pubmed:affiliation |
Helen Wills Neuroscience Institute and the Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720, USA. beth.kuczynski@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Research Support, N.I.H., Extramural
|
